Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Yuichi Muraki"'
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Background In most countries barring Japan, antihypertensive drug use has been reported using the defined daily doses/1000 inhabitants/day (DID). Although DID has been shown to allow for the assessment of the number of patients treated with
Externí odkaz:
https://doaj.org/article/2c3781acac134d7ba589ab8b71ca55c8
Autor:
Ryota Goto, Yuichi Muraki, Ryo Inose, Moeno Ichii, Keisuke Sawada, Kanako Mizuno, Ryuji Koizumi, Shinya Tsuzuki, Masahiro Ishikane, Norio Ohmagari
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Background The loading dose of teicoplanin (TEIC) is recommended for implementation. However, there is significant discrepancy between the dose settings in the package insert and, in the guidelines, and the actual status of loading doses in
Externí odkaz:
https://doaj.org/article/81c79adbedbc4048a7087646f127b6d8
Autor:
Tatsuya Tai, Takahiro Motoki, Kazunori Yamaguchi, Masahiro Watanabe, Taichi Ito, Kyoko Yokota, Kaori Ishikawa, Hiroaki Tanaka, Yuichi Muraki, Shinji Kosaka, Teruki Dainichi
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 4 (2024)
Antimicrobial-product package inserts and insufficient staffing impede routine carbapenem monitoring in the inpatient setting in Japan. The collaboration between antimicrobial stewardship teams and clinical pharmacists was associated with a sustained
Externí odkaz:
https://doaj.org/article/222d6b1120df432a974c92b9d332be21
Autor:
Ryuji Koizumi, Yoshiki Kusama, Yusuke Asai, Shinya Tsuzuki, Kensuke Aoyagi, Masahiro Ishikane, Yuichi Muraki, Norio Ohmagari
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Antimicrobial use (AMU) is conventionally reported as unadjusted defined daily doses (DDDs) or population-adjusted DDDs per 1000 inhabitants per day (DID). DID is frequently used to monitor national AMU trends, this metric does not intrinsic
Externí odkaz:
https://doaj.org/article/25ab511ce61947c0997e3d51bd19ef11
Autor:
Masayuki Maeda, Takefumi Miyake, Ryo Inose, Satoru Ueda, Ken-ichi Matsugi, Yuichi Muraki, Takashi Kitahara
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background Pharmacist plays an integral role in promoting antimicrobial stewardship (AS) strategies by committing to the evidence-based activities in this field. The present study aims to document trends in actual achievements through biblio
Externí odkaz:
https://doaj.org/article/a66dcd659dca47ca91201fd5990c2298
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Shortages of antimicrobials lead to treatment failures, increase medical costs, and accelerate the development of antimicrobial resistance. We evaluated the effects of the serious cefazolin shortage in 2019 in Japan on the sales,
Externí odkaz:
https://doaj.org/article/af7223139b1548b8af89f40af8f89668
Autor:
Akane Ono, Kensuke Aoyagi, Yuichi Muraki, Yusuke Asai, Shinya Tsuzuki, Ryuji Koizumi, Toshiaki Azuma, Yoshiki Kusama, Norio Ohmagari
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The inappropriate use of antimicrobials for acute infectious diarrhea is widespread and leads to the problem of antimicrobial resistance. To improve the use of antimicrobials, it is first necessary to understand the actual situati
Externí odkaz:
https://doaj.org/article/d26e3dc7fa24412b98a6f92c533d7928
Publikováno v:
Antibiotics, Vol 11, Iss 12, p 1807 (2022)
This study aimed to clarify the relationship between carbapenem consumption and clinical outcome using the diagnosis procedure combination (DPC) payment system database (2020) published by the Ministry of Health, Labour, and Welfare of Japan. This st
Externí odkaz:
https://doaj.org/article/4a89579d38044ae1834b43068b1afa2b
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Objective: To compare the incremental costs and healthcare utilization of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with those of methicillin-susceptible S. aureus (MSSA) bacteremia. Design: Retrospective cohort study
Externí odkaz:
https://doaj.org/article/a277fbcbb67648498ef7abecf29ff6eb
Autor:
Ryota Goto, Yuichi Muraki, Ryo Inose, Yoshiki Kusama, Akane Ono, Ryuji Koizumi, Masahiro Ishikane, Norio Ohmagari
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0274324 (2022)
IntroductionMethicillin-resistant Staphylococcus aureus (MRSA) has a high mortality and requires effective treatment with anti-MRSA agents such as vancomycin (VCM). Management of the efficacy and safety of VCM has been implemented with the assignment
Externí odkaz:
https://doaj.org/article/ed71bae7bd4b40fb957da2f4ed109606